SEC Form 4 · accession 0001628280-26-046015
TriSalus Life Sciences, Inc. · TLSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Henry Marshall
Officer — Chief Medical Officer
Period of report
Jun 29, 2026
Accepted (ET)
Jun 29, 2026 · 4:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001826667
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 29, 2026 | A | 60,000 | $0.00 | A | 90,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $4.74 | Jun 29, 2026 | A | 120,000 | A | — | Jun 29, 2036 | Common Stock | 120,000 | 253,000 | D |
Explanation of responses
- F1Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- F2One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.